About this trial

Patients with lung cancer often have reduced physical fitness and coexisting health problems, which may limit their ability to tolerate oncological treatment. Standard resting lung and heart tests do not always reflect real-life physical capacity during everyday activities or physical effort.

This observational study aims to assess cardiorespiratory fitness in patients with lung cancer before and during standard oncological treatment using cardiopulmonary exercise testing (CPET). CPET is a safe, supervised exercise test that provides objective information on how the heart, lungs, and muscles respond to physical effort.

Participants with WHO/ECOG performance status 0-2 will undergo CPET before treatment initiation and again after the early phase of therapy or surgery. The results may help identify patients with reduced physiological reserve and support individualized monitoring during routine clinical care.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Histologically confirmed lung cancer (any stage)

Qualified for standard oncological management (surgery and/or systemic therapy)

WHO/ECOG performance status 0-2

Disqualifiers

Unstable ischemic heart disease

Symptomatic cardiac arrhythmias

Myocarditis or pericarditis

Decompensated heart failure

Trial design

Treatments tested in this trial

  • Cardiopulmonary Exercise Testing (CPET)

Treatment groups

90 Participants
are divided into 1 treatment group

Locations

1
University Clinical Hospital in Bialystok, II Department of Pulmonology, Lung Cancer and Internal Medicine, Medical University of Bialystok15-276, BialystokPodlaskie Voivodeship, Poland

Sponsors and collaborators

Medical University of Bialystok

Lead sponsor